AffiliationDepartment Infectious Diseases, Mater Misericordiae University Hospital, Eccles St., Dublin 7 and University College Dublin, School of Medicine & Medical Sciences, Dublin. firstname.lastname@example.org
Antibodies, Monoclonal, Murine-Derived
Antiretroviral Therapy, Highly Active
Giant Lymph Node Hyperplasia
Herpesvirus 8, Human
MetadataShow full item record
CitationMulticentric Castleman's disease & HIV infection. 2009, 102 (9):294-5 Ir Med J
JournalIrish medical journal
AbstractWe report the case of a 35 year patient from Nigeria who presented with fever and splenomegaly. The initial diagnosis was Salmonellosis. However, relapsing symptoms lead to a re-evaluation and ultimately a diagnosis of Multicentric Castleman's Disease (MCD). There is no gold standard treatment but our patient responded to Rituximab and Highly active anti-retroviral therapy. MCD is a rare, aggressive disease that should be considered in a HIV positive patient presenting with fever and significant lymphadenopathy.
- Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease.
- Authors: van Aalderen MC, Brinkman K, van den Berk GE, Terpstra WE
- Issue date: 2010 Feb
- Multicentric Castleman's disease in a patient with HIV.
- Authors: Fowler A, Collins L, de Ruiter A, Whittaker S, Kulasegaram R, Bradbeer C
- Issue date: 2006 Jan
- Rituximab failure in fulminant multicentric HIV/human herpesvirus 8-associated Castleman's disease with multiorgan failure: report of two cases.
- Authors: Buchler T, Dubash S, Lee V, Chilton D, Cartledge J, Isaacson P, Tedder RS, Lee SM
- Issue date: 2008 Aug 20
- Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab.
- Authors: Ide M, Kawachi Y, Izumi Y, Kasagi K, Ogino T
- Issue date: 2006 Feb
- Fifty years of multicentric Castleman's disease.
- Authors: Waterston A, Bower M
- Issue date: 2004